Search

Search Constraints

You searched for: Author/Creator Homs, Marjolein Y. V.

Search Results

1. Adjuvant and first-line palliative chemotherapy regimens in patients diagnosed with periampullary cancer: a short report from a nationwide registry. (4th May 2022)

2. Circulating TP53 mutations are associated with early tumor progression and poor survival in pancreatic cancer patients treated with FOLFIRINOX. (August 2021)

3. Implementation of contemporary chemotherapy for patients with metastatic pancreatic ductal adenocarcinoma: a population-based analysis. (2nd June 2020)

4. Neoadjuvant Chemoradiotherapy Versus Upfront Surgery for Resectable and Borderline Resectable Pancreatic Cancer: Long-Term Results of the Dutch Randomized PREOPANC Trial. Issue 11 (10th April 2022)

5. Real‐world evidence of adjuvant gemcitabine plus capecitabine vs gemcitabine monotherapy for pancreatic ductal adenocarcinoma. Issue 10 (31st December 2021)

6. The bigger picture of shared decision making: A service design perspective using the care path of locally advanced pancreatic cancer as a case. (30th July 2021)

8. Treatment Response and Conditional Survival in Advanced Pancreatic Cancer Patients Treated with FOLFIRINOX: A Multicenter Cohort Study. (7th July 2022)